SPECTRE Special Pathogens Excellence in Clinical Treatment Readiness & Education Program

Welcome to SPECTRE!

We are SPECTRE—the Special Pathogens Excellence in Clinical Treatment, Readiness, and Education Program—housed within the Division of Infectious Diseases at UTMB. Our mission is to strengthen local and regional readiness to respond to high-consequence infectious diseases, ensuring self-sufficiency and operational resilience.

SPECTRE supports the ongoing preparedness of UTMB’s Biocontainment Care Unit (BCU) by developing targeted training and education initiatives grounded in practical, frontline care. We focus on equipping healthcare professionals, across all of Region 6, with the skills, tools, and confidence needed to act swiftly and safely during special pathogen events.

We also foster collaboration with regional healthcare partners and public health entities, promoting a unified, state-driven response framework that ensures coordination without unnecessary duplication of federal efforts. In addition, we contribute to the infrastructure needed for clinically grounded research, ensuring that emerging knowledge translates directly into improved patient care and safety protocols.

 

Trending Topics

Who is SPECTRE

SPECTRE strengthens healthcare preparedness through training, education, research, and regional coordination. By equipping healthcare professionals with specialized skills, advancing infectious disease research, and leading regional preparedness efforts, SPECTRE enhances the ability to manage high-consequence infectious diseases. This video highlights SPECTRE’s mission and its role in providing healthcare professionals with the knowledge and resources needed to respond effectively. Through evidence-based education, research, and strategic partnerships, SPECTRE helps build stronger response capabilities at institutional, regional, and national levels.

What we do

News & Events

 Latest News

Healthcare workers running down a hallway with a patient

NETEC News & BlogPreparing Before the Outbreak: Key Takeaways on Ebola Vaccines and the Future of Special Pathogen Preparedness

Ebola preparedness requires years of research to develop, test, manufacture, and advance vaccines and treatments before an outbreak occurs. Investing in flexible technologies, broad-spectrum antivirals, and multivalent vaccines can help public health responders respond more quickly and effectively to future emerging infectious disease threats.

Read more

 Upcoming Events